November 14th and 15th 2025 , patients, caregivers, clinicians and researchers from fifteen European countries met in Prague for the 2025 European Vasculitis Patient Summit.

The two-day event highlighted major developments in vasculitis care, including advances in treatment, the emerging potential of CAR-T therapy, and the practical impact of digital care pathways. Speakers also explored the opportunities and risks of artificial intelligence, as well as new insights into the diagnosis and classification of ANCA-associated vasculitis.

The summit welcomed VASKULITIDA.CZ, the newly established Czech patient organisation, and emphasised the importance of strong patient representation in shaping future care.

Participants described the meeting as inspiring, highly informative and an important step towards closer European collaboration.

You will find a more detailed overview of the event here.